Use of digoxin in chronic systolic heart failure in current era

Affiliations

¹ Division of Cardiology, Department of Medicine, VA Boston Healthcare System, Boston Medical Center, West Roxbury, Mass.
² Department of Medicine, MetroWest Medical Center, Framingham, Mass.
³ Department of Medicine, Johns Hopkins University/Sinai Hospital of Baltimore, Baltimore, Md.

Comment

Yutthapong Temtanakitpaisan et al. Am J Med. 2015 Jan.

. 2015 Jan;128(1):e17.

doi: 10.1016/j.amjmed.2014.03.030.

¹ Division of Cardiology, Department of Medicine, VA Boston Healthcare System, Boston Medical Center, West Roxbury, Mass.
² Department of Medicine, MetroWest Medical Center, Framingham, Mass.
³ Department of Medicine, Johns Hopkins University/Sinai Hospital of Baltimore, Baltimore, Md.

No abstract available

Comment in

The reply.
Ahmed A, Fonarow GC, Bourge RC. Ahmed A, et al. Am J Med. 2015 Jan;128(1):e19. doi: 10.1016/j.amjmed.2014.09.014. Am J Med. 2015. PMID: 25553633 No abstract available.

Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure.
Bourge RC, Fleg JL, Fonarow GC, Cleland JG, McMurray JJ, van Veldhuisen DJ, Gheorghiade M, Patel K, Aban IB, Allman RM, White-Williams C, White M, Filippatos GS, Anker SD, Ahmed A. Bourge RC, et al. Am J Med. 2013 Aug;126(8):701-8. doi: 10.1016/j.amjmed.2013.02.001. Epub 2013 Mar 12. Am J Med. 2013. PMID: 23490060 Free PMC article. Clinical Trial.